Phosphodiesterase 5 Inhibitors - Drug Design and Differentiation Based on Selectivity, Pharmacokinetic and Efficacy Profiles

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|27|3459-3465

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.27, 2006-09, pp. : 3459-3465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors

By Blume Henning   Donath Frank   Warnke André   Schug Barbara S.  

Drug Safety, Vol. 29, Iss. 9, 2006-01 ,pp. : 769-784

Adis International

Access to resources Recommend Favorite

Design of Second Generation Phosphodiesterase 5 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 4, 2007-01 ,pp. : 405-419

Bentham Science Publishers

Access to resources Recommend Favorite

Subtype Selectivity in Phosphodiesterase 4 (PDE4): A Bottleneck in Rational Drug Design

By  

Current Pharmaceutical Design, Vol. 14, Iss. 36, 2008-12 ,pp. : 3854-3872

Bentham Science Publishers

Access to resources Recommend Favorite

Mining ZINC Database to Discover Potential Phosphodiesterase 9 Inhibitors Using Structure-Based Drug Design Approach

By  

Medicinal Chemistry, Vol. 12, Iss. 5, 2016-08 ,pp. : 472-477

Bentham Science Publishers

Access to resources Recommend Favorite

ADMET considerations for phosphodiesterase-5 inhibitors

By Rezvanfar Mohammad Amin   Rahimi Hamid Reza   Abdollahi Mohammad  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 10, 2012-10 ,pp. : 1231-1245

Informa Healthcare

Access to resources Recommend Favorite